Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 498.72 million compared to CNY 429.64 million a year ago. Revenue was CNY 500.02 million compared to CNY 430.97 million a year ago.

Net income was CNY 54.25 million compared to CNY 44.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.58 compared to CNY 0.52 a year ago. Diluted earnings per share from continuing operations was CNY 0.58 compared to CNY 0.5 a year ago.